Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC

Name: Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC
Published: 1995
License: Public Domain

National Cancer Institute (NCI) · 1995

ClinicalTrials.gov · Datasets · License: Public Domain · 1995

Open Source ↗

carcinoma chemotherapy lung-neoplasms pharmacokinetics

carcinoma, non-small-cell lung, lung neoplasms, chemotherapy, in vitro testing, infusional, lung neoplasm, pharmacokinetics, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC

Related documents